Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis
Development of a gene delivery system with high efficiency and a good safety profile is essential for successful gene therapy. Here we developed a targeted non-viral delivery system using a multifunctional lipid ECO for treating Leber’s congenital amaurosis type 2 (LCA2) and tested this in a mouse m...
Main Authors: | Da Sun, Bhubanananda Sahu, Songqi Gao, Rebecca M. Schur, Amita M. Vaidya, Akiko Maeda, Krzysztof Palczewski, Zheng-Rong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117301324 |
Similar Items
-
A Gene Scan Study of RPE65 in Chinese Patients with Leber Congenital Amaurosis
by: Jing Liu, et al.
Published: (2017-01-01) -
Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis
by: Maximilian J. Gerhardt, et al.
Published: (2022-12-01) -
Leber’s Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations
by: Chu-Hsuan Huang, et al.
Published: (2021-08-01) -
Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing
by: Dong Hyun Jo, et al.
Published: (2023-03-01) -
Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
by: Alcina K. Lidder, et al.
Published: (2023-12-01)